MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 93 filers reported holding MEI PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,197 | -43.8% | 48,918 | -40.2% | 0.00% | – |
| Q4 2022 | $19,941 | +17.3% | 81,858 | +84.8% | 0.00% | – |
| Q3 2022 | $17,000 | -82.5% | 44,297 | -72.3% | 0.00% | – |
| Q2 2022 | $97,000 | -86.4% | 160,089 | -86.5% | 0.00% | – |
| Q1 2022 | $715,000 | -75.3% | 1,185,573 | +9.6% | 0.00% | -100.0% |
| Q4 2021 | $2,889,000 | -6.1% | 1,081,891 | -3.0% | 0.00% | 0.0% |
| Q3 2021 | $3,077,000 | -37.8% | 1,114,885 | -35.8% | 0.00% | 0.0% |
| Q2 2021 | $4,947,000 | -39.6% | 1,735,810 | -27.3% | 0.00% | -50.0% |
| Q1 2021 | $8,186,000 | +29.8% | 2,386,548 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $6,309,000 | -28.3% | 2,389,842 | -15.2% | 0.00% | 0.0% |
| Q3 2020 | $8,798,000 | -24.7% | 2,819,871 | -0.3% | 0.00% | -50.0% |
| Q2 2020 | $11,684,000 | +578.5% | 2,829,152 | +164.5% | 0.00% | +300.0% |
| Q1 2020 | $1,722,000 | +1040.4% | 1,069,585 | +1670.0% | 0.00% | – |
| Q2 2019 | $151,000 | -27.8% | 60,430 | +24.6% | 0.00% | – |
| Q3 2018 | $209,000 | +54.8% | 48,508 | +40.7% | 0.00% | – |
| Q2 2018 | $135,000 | +400.0% | 34,488 | +167.3% | 0.00% | – |
| Q1 2018 | $27,000 | -20.6% | 12,900 | -20.7% | 0.00% | – |
| Q4 2017 | $34,000 | +78.9% | 16,269 | +49.3% | 0.00% | – |
| Q3 2016 | $19,000 | +11.8% | 10,900 | -17.3% | 0.00% | – |
| Q1 2016 | $17,000 | -57.5% | 13,175 | -47.9% | 0.00% | – |
| Q4 2015 | $40,000 | -13.0% | 25,268 | +134.4% | 0.00% | – |
| Q4 2014 | $46,000 | – | 10,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|